13222
clinical study

Enhancing Pulmonary Embolism Management: The Impact of AI-Based Triage and Prioritization on Diagnostic Timeliness and Treatment Initiation

Materials & Methods

This retrospective study analyzed patients who underwent CT pulmonary angiogram (CTPA) for pulmonary embolism (PE) detection between Sept. 2023 and March 2024 using AI-based triage software. It examined the time from scan completion to clinical notification (NT) and the time to anticoagulation initiation (TTA) by reviewing radiology reports and patient charts.

Results

The study included 325 patients in the pre-AI group and 157 in the post-AI group. Results showed a significant reduction in NT in the post-AI group (mean: 33.54 minutes, interquartile range (IQR): 25 minutes) compared to the pre-AI group (mean: 64.41 minutes, IQR: 28 minutes) (p < 0.05). TTA also significantly decreased in the post-AI group (mean: 149.22 minutes, IQR: 93.75 minutes) vs. the pre-AI group (mean: 248 minutes, IQR: 197 minutes) (p < 0.05).

Conclusions

The AI-based triage system significantly reduced NT and TTA times for PE detection. These results demonstrate AI’s potential to enhance diagnostic efficiency, accelerate clinical responses and improve patient outcomes.

Disclaimer: This links to a third-party website, which may require credentials to review.

Explore the Latest AI Insights, Trends and Research

Daniel Spector

<p>Daniel Spector is an AI Transformation Consultant at Aidoc. His focus is enabling clinicians and hospital administrators to provide better, more efficient care through the power of AI augmentation for enterprise imaging.</p>

Amalia Schreier

<p>Amalia Schreier serves as the Senior Vice President of Regulatory Affairs and Legal at Aidoc, guiding our company and product’s regulatory strategies and ensuring alignment with AI-focused medical device compliance requirements. Since her tenure began, she has streamlined our FDA clearance processes, emphasizing a meticulous approach that underscores our commitment to product and clinical quality.</p> <p>With a solid foundation from her legal background and leadership role in AI startup regulatory departments, Schreier brings invaluable insights and expertise to our regulatory framework. Prior to her tech world experience, she worked as a human-rights lawyer and legal policy scholar, with a BA and LLM in law from the Hebrew University of Jerusalem.</p>

Deepak Srikant

<p>Deepak Srikant is a global marketing executive with over 20 years of experience, specializing in the commercialization of medical devices and digital health solutions. He has a proven track record in driving growth, having led successful go-to-market strategies, product launches and market expansions across the U.S. and EMEA.</p> <p>Srikant’s expertise extends to upstream and downstream marketing, professional education and sales enablement. His leadership at companies such as Silk Road Medical (acquired by Boston Scientific) and Aptus Endosystems (acquired by Medtronic) has consistently resulted in revenue growth, enhanced customer retention and successful product adoption.</p> <p>Srikant holds an MBA from the Yale School of Management and a bachelor’s degree in mechanical engineering from Rensselaer Polytechnic Institute. Currently, he leads product marketing for Aidoc’s cardiovascular service line.</p>